Safety of infliximab: primum non nocere. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients
Inflamm Bowel Dis
.
2004 Jul;10(4):486-7.
doi: 10.1097/00054725-200407000-00028.
Authors
Mansour A Parsi
1
,
Bret A Lashner
Affiliation
1
Center for Inflammatory Bowel Disease, Department of Gastroenterology and Hepatology, The Cleveland Clinic Foundation, USA.
PMID:
15475765
DOI:
10.1097/00054725-200407000-00028
No abstract available